Significant Ownership of CK Life Sciences Intl (Holdings) Inc

Signature - Title
/s/ Yu Ying Choi, Alan Abel - Yu Ying Choi, Alan Abel/Manager
Location
Central, Hong Kong
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by CK Life Sciences Intl (Holdings) Inc.

Notify me when CK Life Sciences Intl (Holdings) Inc files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of CK Life Sciences Intl (Holdings) Inc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RNAZ TransCode Therapeutics, Inc. Common Stock 9.1% $871K 83.3K 0% CK Life Sciences Int'l., (Holdings) Inc. 27 Oct 2025

Schedules 13D/G Reported by CK Life Sciences Intl (Holdings) Inc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.